SCOTT RIOCH: Open Payments
NPI 1619947272 · FINDLAY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,780 in 166 payments from 26 companies in 2025. Trend: 2023 $2,522 · 2024 $2,528 · 2025 $2,780
Food & beverage: $2,780
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $406 |
| Novo Nordisk Inc | 26 | $345 |
| Lilly USA, LLC | 10 | $178 |
| AstraZeneca Pharmaceuticals LP | 9 | $176 |
| Axsome Therapeutics, Inc. | 12 | $168 |
| Aimmune Therapeutics, Inc. | 9 | $163 |
| Otsuka America Pharmaceutical, Inc. | 9 | $156 |
| GlaxoSmithKline, LLC. | 8 | $132 |
| Esperion Therapeutics, Inc. | 7 | $115 |
| PFIZER INC. | 6 | $97 |
Products named: VRAYLAR, Ozempic, ZENPEP, REXULTI, TRELEGY ELLIPTA, NEXLETOL, MOUNJARO, FARXIGA.
Industry payments across OH — which companies pay providers there.
